Ignite Creation Date:
2025-12-25 @ 12:44 AM
Ignite Modification Date:
2025-12-30 @ 11:49 PM
Study NCT ID:
NCT02795767
Status:
COMPLETED
Last Update Posted:
2021-06-02
First Post:
2016-06-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Emicizumab Administered Subcutaneously (SC) in Pediatric Participants With Hemophilia A and Factor VIII (FVIII) Inhibitors
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-07-22
Start Date Type:
ACTUAL
Primary Completion Date:
2018-04-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-11-11
Completion Date Type:
ACTUAL
First Submit Date:
2016-06-07
First Submit QC Date:
None
Study First Post Date:
2016-06-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-03-20
Results First Submit QC Date:
None
Results First Post Date:
2019-04-10
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-05-07
Last Update Post Date:
2021-06-02
Last Update Post Date Type:
ACTUAL